UroGen

UroGen Pharma

This company develops and commercialises hydrogel-based medicines for patients with urological and specialty cancers, including treatments for low-grade upper tract urothelial carcinoma and bladder cancer.

Combat Medical

This company manufactures hyperthermic drug delivery systems for hospitals and oncology clinics to treat patients with bladder and peritoneal cancers.

Speciality European Pharma

This company develops and distributes pharmaceutical products and medical devices for urological and gynaecological conditions to specialist physicians and hospitals across Europe.

Tympanogen

This medical device company develops a gel patch for eardrum repair, selling to ear, nose and throat surgeons and outpatient clinics.

CG Oncology

This biopharmaceutical company develops oncolytic immunotherapies for patients with non-muscle invasive bladder cancer.

Exomnis Biotech

This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.

Aura Biosciences

This biotechnology company develops virus-like drug conjugates to treat patients with solid tumours, specifically targeting ocular and bladder cancers.

enGene

This clinical-stage biotechnology company develops non-viral gene therapies for patients with high-risk, non-muscle invasive bladder cancer and other mucosal tissue diseases.